RA0740

antibody from Oursmab

Targeting: TLR2 CD282, TIL4

Western blot

ELISA

Immunocytochemistry

Flow cytometry

Functional assay

Antibody data

Submit

Validation data

Product number: RA0740 - Provider product page
Provider: Oursmab
Product name: Tomaralimab (Biosimilar Reference Antibody) (TLR2)
Antibody type: Monoclonal
Description: Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting Toll-like receptor 2 (TLR2), a pattern recognition receptor involved in innate immune activation. It binds to TLR2 to block its interaction with pathogen- and damage-associated molecular patterns (PAMPs/DAMPs), thereby inhibiting downstream pro-inflammatory signaling. It is being developed for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, atherosclerosis, and organ transplant ischemia-reperfusion injury.
Reactivity: Human
Isotype: IgG
Vial size: 100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration: Bottled at the concentration indicated on the vial.
Storage: Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

TLR2 protein structure - RA0740 shown in red.